BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12874077)

  • 21. [Regional metastases of head and neck cutaneous squamous cell carcinoma].
    de Heer AR; Bouman H; Gerritsen MJ; Ingels KJ; Kaanders JH; Takes RP
    Ned Tijdschr Geneeskd; 2008 Dec; 152(49):2645-9. PubMed ID: 19137960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphatic metastases in the parotid region from malignant skin neoplasm of the head: considerations for surgical treatment based on personal clinical experience].
    Tullio A; Bianchi B; Sesenna E
    Acta Otorhinolaryngol Ital; 2001 Feb; 21(1):44-9. PubMed ID: 11434222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite.
    Turner SJ; Morgan GJ; Palme CE; Veness MJ
    J Laryngol Otol; 2010 Jan; 124(1):26-31. PubMed ID: 19775493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease.
    Veness MJ; Palme CE; Morgan GJ
    Cancer; 2006 Jun; 106(11):2389-96. PubMed ID: 16649220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma.
    Clark J; Li W; Smith G; Shannon K; Clifford A; McNeil E; Gao K; Jackson M; Mo Tin M; O'Brien C
    Head Neck; 2005 Feb; 27(2):87-94. PubMed ID: 15627246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parotid area lymph node metastases from cutaneous squamous cell carcinoma: implications for diagnosis, treatment, and prognosis.
    Hong TS; Kriesel KJ; Hartig GK; Harari PM
    Head Neck; 2005 Oct; 27(10):851-6. PubMed ID: 16114004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma of the parotid gland.
    Ying YL; Johnson JT; Myers EN
    Head Neck; 2006 Jul; 28(7):626-32. PubMed ID: 16475198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Exclusive radiotherapy of parotid metastases. Results in 14 cases].
    Krengli M; Pisani P; Pia F
    Radiol Med; 1993 Nov; 86(5):684-6. PubMed ID: 8272555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parotideal lymph node metastasis in squamous cell carcinoma of the skin.
    Teymoortash A; Dünne AA; Werner JA
    Eur J Dermatol; 2002; 12(4):376-80. PubMed ID: 12095888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of clinical stage, extent of surgery and outcome in cutaneous squamous cell carcinoma of the head and neck.
    Košec A; Svetina L; Lukšić I
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):82-8. PubMed ID: 23137734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.
    Boahene DK; Olsen KD; Lewis JE; Pinheiro AD; Pankratz VS; Bagniewski SM
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):849-56. PubMed ID: 15262762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
    Bumpous J
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elective parotidectomy in the management of advanced auricular malignancies.
    Osborne RF; Shaw T; Zandifar H; Kraus D
    Laryngoscope; 2008 Dec; 118(12):2139-45. PubMed ID: 19029866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
    Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
    Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage.
    Al-Othman MO; Mendenhall WM; Amdur RJ
    Am J Otolaryngol; 2001; 22(6):387-90. PubMed ID: 11713722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic disease to the parotid gland.
    Nuyens M; Schüpbach J; Stauffer E; Zbären P
    Otolaryngol Head Neck Surg; 2006 Dec; 135(6):844-8. PubMed ID: 17141071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.